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Abstract
Intake of trans fatty acids unfavorably affects blood lipoproteins. As margarines are a major source of trans, claims for the
advantages of margarines over butter need to be scrutinized. Here we review dietary trials that directly compared the effects of
butter and margarine on blood lipids. We identified 20 studies in which subjects had stable body weights, and margarine and
butter were exchanged in the diet at constant energy and fat intake. We calculated the changes in average blood lipid levels
between study diets (49 comparisons) as a function of the percentage of calories as margarine substituted for butter. Replacing
10% of calories from butter by hard high-trans stick margarines lowered total serum cholesterol by 0.19, LDL by 0.11, and HDL
by 0.02 mmol/l, and did not affect the total/HDL cholesterol ratio. Soft low-trans tub margarines decreased total cholesterol by
0.25 and LDL by 0.20 mmol/l, did not affect HDL, and decreased the total/HDL cholesterol ratio by 0.20. Based on the
total/HDL cholesterol ratio, replacement of 30 g of butter per day by soft tub margarines would theoretically predict a reduction
in coronary heart disease risk of 10%, while replacement of butter by hard, high-trans margarines would have no effect. Replacing
butter by low-trans soft margarines favorably affects the blood lipoprotein profile and may reduce the predicted risk of coronary
heart disease, but high-trans hard margarines probably confer no benefit over butter. © 1997 Elsevier Science Ireland Ltd.
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1. Introduction
Hypercholesterolemia affects large numbers of people
in affluent and increasingly also in developing coun-
tries. Diets low in saturated fat have long been the first
line of treatment, especially for moderately elevated
cholesterol levels. A standard feature of such diets is
restricting the intake of butter and milk fat, and partly
replacing them by fats of vegetable origin, including
margarines. However, new findings on the effects of
trans fatty acids on blood lipoproteins have thrown
doubts on the value of margarines for improving the
lipoprotein risk profile. Dietary trans fatty acids raise
LDL cholesterol and lower HDL cholesterol in humans
[1–3]. Some [4–7], but not all [8,9], epidemiologic
studies also indicate that high intakes of trans fatty
acids increase coronary heart disease (CHD) risk. Mar-
garines have long had a ‘healthy’ image because they
are lower in saturated fatty acids and cholesterol than
butter. However, some margarines are also rich in trans
fatty acids. As a result the putative health benefits of
margarine need to be reassessed [10–13]. Here we re-
view the effects of butter and margarine on lipoprotein
cholesterol concentrations as risk factors for coronary
heart disease.
* Corresponding author. Tel.: +31 317 482646 or 2589; fax: +31
317 483342; e-mail: martijn.katan@et3.voed.wau.nl
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2. Methods
2.1. Selection of studies
We screened MEDLINE (1966–1995), Biological
Abstracts (1991–1995), and reference lists of pertinent
articles and reports for experimental studies of the
effects of butter, dairy or milk fat, margarine, or hard-
ened or (partially) hydrogenated fat. Twenty-eight stud-
ies directly compared the effects of butter and
margarine on blood lipids in humans.
We selected studies in which subjects had stable body
weights, at least two-thirds of the intervention consisted
of exchanging margarine isocalorically for butter and
dairy fats, and in which differences in total fat or
carbohydrates between the margarine and the butter
diets made up less than 3% of energy intake. This
yielded 20 studies [3,14–32] which provided 49 dietary
comparisons (Table 1). Twelve were metabolic-ward
trials in which all food was provided, and eight em-
ployed free-living subjects who were provided with the
fats under investigation. Experimental diets were con-
sumed for 8–175 days, and margarine or butter pro-
vided between 5 and 45% of total caloric intake.
We classified the margarines as hard (stick or wrap-
per) or soft (tub). Most studies used commercial mar-
garines, but some also investigated fat blends suitable
for margarine production. The majority of the margari-
nes were made of partially hydrogenated or unmodified
vegetable oils. The remainder contained lard, tallow, or
partially hydrogenated fish or whale oil (Table 1).
Missing information on dietary intervention and the
fatty acid composition of the margarines was obtained
from the authors [25,28,29] or was estimated from data
on commercial margarines that were current at the time
of the study in question [17,19,26].
2.2. Data analysis
We calculated the changes in serum or plasma total,
LDL, and HDL cholesterol levels, in the ratio of total
to HDL cholesterol, and in triglyceride levels as a
function of the amount of margarine exchanged for
butter (percentage of total caloric intake). Regression
analyses were performed using the General Linear
Models (GLM) procedure of the SAS package [33]. For
cross-over and sequential designs we subtracted the
mean level at the end of the margarine period from that
at the end of the butter period. For parallel studies, we
calculated the difference between the changes on the
two treatments. Exchanging margarine for butter com-
prised on average 97% of calories of the total dietary
intervention. For cross-over and parallel studies, the
observed changes could be fully attributed to the re-
placement of butter by margarine, because the study
design eliminates drift of variables over time. For se-
quential designs, spurious changes may be observed
because subjects’ lipid levels may decrease when they
participate in dietary trials, regardless the nature of the
dietary intervention. However, of the 13 comparisons
with a sequential design (Table 1), seven first supplied
the margarine diet and then the butter diet, and the
other six first supplied the butter diet. As a result, the
effect of drifts of lipid and lipoprotein levels with time
on the difference between margarine and butter proba-
bly averaged out in the combined estimates. Thus,
changes were almost completely attributable to the
dietary fats themselves, and zero substitution should
produce no change. Therefore, regression lines were
forced through the origin.
In analyses of the relation between changes in lipo-
protein cholesterol levels and trans and saturated fatty
acid content, regression lines were not forced through
the origin, because other aspects of the margarines, e.g.
content of other fatty acids or cholesterol, may vary
and affect lipoprotein levels independent of the trans or
saturated fatty acid content.
The number of subjects varied among the trials. To
take this into account, it is usual in meta-analyses to
weight each study by the reciprocal of the squared
standard error. Most studies did not report the stan-
dard error of the differences in lipoprotein levels be-
tween subjects on butter and on margarine. We
therefore weighted by the square root of the number of
subjects, which is inversely proportional to the standard
error. This yielded results essentially similar to those
obtained by unweighted analysis; therefore we present
only unweighted results.
3. Results
Twenty studies comprising 49 comparisons of butter
and margarine met our criteria. These were published
between 1957 and 1995 (Table 1). Most studies pro-
vided one or two dietary comparisons, but de Iongh et
al. provided five [22], and Beveridge et al. 16 [20]. Ten
studies published between 1980 and 1995 and compris-
ing 15 dietary comparisons provided data on HDL
cholesterol.
In 32 comparisons involving a total of 402 subjects
hard stick or ‘brick’ margarine was used; the other 17
comparisons, involving 939 subjects, used soft tub mar-
garines. In five comparisons margarine containing par-
tially hydrogenated fish oils was used. Fig. 1 shows the
average composition of butter and of the margarines in
the studies reviewed here. Butter contains on average 51
g saturated, 3 g trans, 21 g cis-monounsaturated, and 2
g of cis-polyunsaturated fatty acids per 100g. The
margarines on average contained 20 g saturated, 18 g
trans (range 0–39 g), 22 g cis-monounsaturated, and 18
g of cis-polyunsaturated fatty acids per 100 g of

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































P.L. Zock, M.B. Katan / Atherosclerosis 131 (1997) 7–16 11
Fig. 1. Composition, in g per 100 g of product, of butter and of the
average stick margarines (N=32) and tub margarines (N=17) used
in the 20 experiments reviewed. Sat, saturated fatty acids; Trans, trans
fatty acids; Mono, cis-monounsaturated fatty acids; Poly, polyunsat-
urated fatty acids; and H20, water plus glycerol and other minor
substances. Butter contains about 220 mg, vegetable margarines less
than 1 mg, and margarines made with animal fats 70–275 mg
cholesterol per 100 g of product.
Fig. 3. Changes in LDL cholesterol levels on margarine versus butter
diets in 20 studies providing 49 comparisons. () Hard stick vegetable
margarine; (
) hard stick margarine with partially hydrogenated fish
oil; and () soft tub margarine.product. The most abundant saturated fatty acid in
both butter and margarine was palmitic acid (C16:0),
followed in butter by myristic acid (C14:0) and fol-
lowed by stearic acid (C18:0) in margarines. Hard stick
or ‘brick’ margarines contained 16 g more trans and 19
g less polyunsaturated fatty acids per 100 g than the
softer tub margarines (Fig. 1).
3.1. Effects on lipoprotein cholesterol
Substitution of margarine for butter lowered the total
cholesterol level in 46 out of 49 comparisons (Fig. 2);
for all margarines combined cholesterol decreased on
average by 0.21 mmol/l (PB0.001; 95% CI, −0.23 to
−0.18 mmol/l) per 10% of daily calories as margarine
substituted for butter. Total cholesterol was lowered by
0.19 mmol/l (95% CI; −0.22 to −0.16 mmol/l) on
stick and by 0.25 mmol/l (95% CI, −0.30 to −0.20
mmol/l) on tub margarine per 10% of calories ex-
changed (P=0.05 for difference between stick and tub
margarine). Excluding margarines containing partially
hydrogenated fish oil did not change these results.
LDL cholesterol decreased by 0.15 mmol/l for all
margarines combined (N=18; PB0.001; 95%CI, −
0.22 to −0.08 mmol/l) (Fig. 3). It was lowered by 0.11
mmol/l per 10% of calories on stick (N=8; P=0.066;
95% CI, −0.24 to +0.01 mmol/l) and by 0.20 mmol/l
on tub margarine (N=10; PB0.001; 95% CI, −0.28
to −0.11 mmol/l; P=0.40 for difference between stick
and tub margarine). If margarines with hydrogenated
fish oil were excluded, hard margarine lowered LDL
cholesterol by 0.17 mmol/l (N=6; P=0.021; 95% CI,
−0.29 to −0.03 mmol/l).
Fig. 4 shows the changes in HDL cholesterol and
Fig. 5 those in the total/HDL cholesterol ratio. Stick
margarine lowered HDL cholesterol by 0.02 mmol/l
(N=5; P=0.045; 95% CI, −0.04 to −0.00 mmol/l)
and non-significantly raised the total/HDL cholesterol
Fig. 4. Changes in HDL cholesterol levels on margarine versus butter
diets in 20 studies providing 49 comparisons. () Hard stick vegetable
margarine; (
) hard stick margarine with partially hydrogenated fish
oil; () soft tub margarine.
Fig. 2. Changes in total cholesterol levels on margarine versus butter
diets in 20 studies providing 49 comparisons. () Hard stick vegetable
margarine; (
) hard stick margarine with partially hydrogenated fish
oil; and () soft tub margarine.
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Fig. 5. Changes in the total to HDL cholesterol ratio on margarine
versus butter diets in ten studies providing 15 dietary comparisons.
() Hard stick vegetable margarine; (
) hard stick margarine with
partially hydrogenated fish oil; () soft tub margarine. The dashed
line represents the regression line for vegetable stick margarines.
4. Discussion
4.1. Lipoprotein cholesterol
Replacement of butter by margarine reduced the
total and LDL cholesterol concentration, but hard stick
margarines also produced somewhat lower HDL
cholesterol levels. As a result the total to HDL choles-
terol ratio was not significantly changed. Soft tub mar-
garines did significantly reduce the total to HDL
cholesterol ratio. This ratio is probably the best blood
lipid predictor of coronary heart disease [35], and high
values are associated with markedly increased risk [36].
Our data thus suggest that improvement of the lipo-
protein risk profile through replacement of butter by
margarine is feasible but that it depends on the type,
and consequently the fatty acid composition, of the
margarine.
4.2. Fatty acid composition of margarines
Some margarines are an important source of dietary
trans fatty acids, while butter is high in saturated fatty
acids but contains only a low proportion of trans. Trans
fatty acids and saturates produce similarly high levels
of LDL cholesterol in plasma, but trans fatty acids also
lower HDL cholesterol [37]. One might therefore expect
that substitution of margarines for butter would in-
crease the ratio of total to HDL cholesterol in plasma,
or at best leave it unchanged. However, we found that
soft margarines decreased the ratio of total to HDL
cholesterol as compared with butter, whereas hard mar-
garines did not. The explanation of these findings prob-
ably lies in the absolute amounts of trans and saturated
fatty acids in butter in comparison with margarines. As
illustrated in Fig. 1, the combined amount of saturated
plus trans fatty acids in the studies reviewed was about
54/100 g for butter, 45/100 g for hard stick margarines
and about 26/100 g for softer tub margarines, the
remainder being cis-unsaturated fatty acids. Analysis of
food fats sold nowadays in the US and Europe [38,39]
also shows that the saturated plus trans fatty acid
content is commonly highest in butter, intermediate in
stick, and lowest in tub margarines. Replacement of
butter by margarine thus involves replacing saturated
fat by a mix of trans and cis unsaturated fat. If the
proportion of trans is high, as it is in stick margarines,
the effect on the total to HDL cholesterol ratio in
plasma will be nil. If butter is replaced by a margarine
low in trans and high in cis-unsaturated fat the total/
HDL cholesterol ratio in plasma will fall [40]. Hard
margarines with partially hydrogenated fish oil may
contain higher amounts of saturated plus trans fatty
acids than butter; the study by Almendingen et al. [3]
shows that such margarines may increase the total/
HDL cholesterol ratio compared with butter and with
ratio by 0.01 units (P=0.83) per 10% of calories rela-
tive to butter. Soft tub margarines did not significantly
affect HDL cholesterol levels (−0.01 mmol/l; N=10;
P=0.45) and lowered the total/HDL cholesterol ratio
by 0.20 units (PB0.002; 95% CI, −0.29 to −0.10,
PB0.025 for difference with stick margarine). For stick
margarines, these estimates were based on five compari-
sons involving 172 subjects. The one comparison using
margarine with partially hydrogenated fish oil [3]
showed a substantial increase in the total/HDL choles-
terol ratio not observed for the other hard margarines.
The vegetable stick margarines combined lowered the
total/HDL cholesterol ratio non-significantly by 0.06
units per 10% of calories exchanged (N=4; P=0.094;
95% CI, −0.14 to 0.02), which was still significantly
smaller than the reduction of 0.20 seen with soft tub
margarines.
Forty-six percent of the variance in the change in
total cholesterol when margarine replaced butter was
explained by the reduction in saturated fatty acids,
whereas the change in trans fatty acid intake explained
only 11%. In contrast, the change in the ratio of total to
HDL cholesterol in plasma was significantly predicted
only by the change in trans fatty acid intake (Fig. 6)
(r2=42%, P=0.009), but not by the change in satu-
rated fatty acid intake (r2=2%, P=0.62).
3.2. Other cardio6ascular risk factors
Effects on serum triglycerides were minimal. Changes
in apolipoprotein A-I and B generally followed changes
in HDL and LDL cholesterol [3,24,28,31,32]. Margari-
nes raised lipoprotein(a) levels in two studies [3,29]
compared with butter. A high-linoleic acid, low-trans
margarine was reported to prolong blood clotting time
[34].
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hard margarines containing partially hydrogenated veg-
etable oils (Fig. 5).
European soft margarines nowadays contain less
trans than the products reviewed here (Fig. 1) or sold in
the US [39,41]. Such soft margarines are low in satu-
rated and free of trans fatty acids, and are thus ex-
pected to produce somewhat lower total/HDL ratios
than the soft margarines reviewed here.
Until recently, stick margarines in both Europe and
the US contained 15–25 g trans per 100 g product
[39,42]. Outside the US, hard margarines are increas-
ingly made with tropical oils instead of partially hydro-
genated oils, both because of price and because of the
negative publicity about trans fatty acids. This confers a
health benefit if the sum of trans plus saturated fatty
acids in the product is lowered, but not if a decrease in
trans fatty acids is bought at the expense of a larger
increase in lauric, myristic, or palmitic acid, which will
raise LDL cholesterol [43]. For optimal effects on the
lipoprotein profile, the sum of trans plus saturated fat
in margarines should be as low as possible.
Replacement of butter by vegetable margarines also
reduces cholesterol intake, and this accounts for about
30% of the fall in total cholesterol observed here (Fig.
2) [44,45]. However, the reduction in dietary cholesterol
also lowers HDL cholesterol [46–49]; therefore the
observed changes in the total to HDL cholesterol ratio
are probably due to changes in fatty acid rather than
cholesterol intake.
4.3. Methodological issues
The number of subjects varied widely between stud-
ies. However, weighting each comparison by the square
root of the number of subjects yielded results virtually
identical to those obtained by unweighted regression.
Stratification of the dietary comparisons according to
study design (cross-over, parallel, or sequential) or ac-
cording to study setting (metabolic ward versus free-liv-
ing) also did not affect outcomes. However, the effects
of study setting could not be separated from the effect
of the type of margarine used (Table 1); soft margarines
were predominantly tested in free-living settings, where
the amount of margarine consumed may have been less
then prescribed. The effects of soft margarines could
thus have been underestimated. Excluding one study
[20] which provided 16 comparisons for total choles-
terol did not affect outcomes. Thus, our findings
changed little when different analytical approaches
were used.
4.4. Labelling of food fats
Our data suggest that knowledge of the saturated fat
content of dietary fats is not sufficient to predict their
effect on coronary heart disease risk. Changes in satu-
rated fat intake predicted 46% of the variance of the
change in total cholesterol but none of that in the total
to HDL cholesterol ratio, which is a better predictor of
coronary heart disease than the level of total cholesterol
[36]. In contrast, the change in trans fat predicted 42%
of the change in the total/HDL cholesterol ratio. Fig. 6
illustrates that the total/HDL cholesterol ratio was
favourably affected in those experiments in which mar-
garine supplied about the same amount of trans fatty
acids as butter (zero change), and was less affected or
increased with margarines supplying larger amounts of
trans fat. This is consistent with the unfavourable effect
of trans fatty acids on the total/HDL cholesterol ratio
observed in recent trials [50]. Food labelling regulations
in most countries require declaration of the saturated
fat content but not of the trans content. Nearly half of
the margarines sold nowadays in the US are of the
more traditional stick type, which contain substantial
amounts of trans fatty acids [51]. Adding the trans
contents on labels would help patients with moderate
hypercholesterolemia to select foods that lower their
total to HDL cholesterol ratio in blood.
4.5. Predicted consequences for CHD risk
Each 0.6 mmol/l decrease in total or LDL cholesterol
reduces coronary heart disease risk by 50% at age 40
[52]. Based on these figures, substituting 10% of calories
or 30 g of margarine for butter (25 g of triglycerides) in
a 2200 kcal diet would reduce CHD risk by 9–16% for
stick and by 17–21% for tub margarine. However, such
an approach ignores changes in HDL cholesterol in-
duced by margarines. There is evidence that HDL is
causally involved in atherosclerosis [53–57] and thus a
more prudent approach should take changes in plasma
HDL into account. We therefore based calculations of
heart disease risk on the ratio of total to HDL choles-
Fig. 6. Changes in the ratio of total to HDL cholesterol in 15 dietary
comparisons as a function of the change in trans fatty acid intake
accompanying the replacement of butter with margarine. () Hard
stick vegetable margarine; (
) hard stick margarine with partially
hydrogenated fish oil; () soft tub margarine.
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terol, which is a superior measure compared with either
total or LDL cholesterol [36].
Our estimate of the effect of hard stick margarine on
total/HDL cholesterol was based on five data points
(Fig. 5), but these comprised a total of 172 subjects
studied in properly controlled trials in three locations
over periods of 3–12 weeks. Elimination of the one
outlying comparison did not materially affect the esti-
mate. We therefore regard our estimate as the best
figure currently available for the effect of hard stick
margarine on the total/HDL cholesterol ratio. Every
reduction of 0.01 in this ratio reduces the risk of
myocardial infarction by approximately 0.5% [35]. This
would imply that replacing 30 g of butter with stick
margarine would not affect CHD risk, while replacing
butter with soft tub margarine would reduce the risk by
10%. A still larger risk reduction might be achieved by
replacing butter and other hard fats with modern low-
saturated zero-trans margarines, which have a fatty acid
composition approximating that of liquid oils [58].
Our risk predictions agree with the outcomes of the
Finnish Mental Hospital Study [59,60], in which re-
placement of butter and dairy fats by a soft margarine
low in trans and high in cis-polyunsaturated fatty acids
lowered CHD incidence by 45% in the men (P=0.008)
and by 36% in the women (P=0.07) during 6 years of
treatment. As for other risk factors, trans fatty acids
raise lipoprotein(a) levels [3,29,61]; this might cause
some additional increase in CHD risk when large
amounts of hard trans-rich margarines are consumed.
Blood pressure is probably not affected by exchanging
butter and margarine [62–65]. The effects of different
fatty acids on blood clotting tendency and fibrinolysis
are poorly understood, but some studies tend to favour
cis-unsaturated over saturated fatty acids [34,66,67].
Cholesterol in butter probably does not affect the total
to HDL cholesterol ratio, but it has been argued that
dietary cholesterol is atherogenic-independent of its
effect on lipoprotein cholesterol [68]. This would imply
that reducing cholesterol intake by substituting mar-
garine for butter would add to the CHD risk reduction
caused by changes in fatty acid intake.
In US Nurses, consumption of margarines and of
trans fatty acids from vegetable fats was associated with
a significant increase in CHD risk [5]. In Framingham,
consumption of margarine—but not butter—at entry
was associated with CHD incidence in men in the next
20 years [69]. The Nurses recorded their diets in 1980
and the Framingham men in 1966–69, and it is likely
that the margarines and shortenings consumed in the
US at that time were mainly hard, high-trans products
[70]. In the Iowa Women’s Health Study, consumption
of margarine was negatively associated with CHD mor-
tality [71]. This association weakened after adjustment
for vitamin E intake, suggesting that it could be partly
attributed to protection by vitamin E. However, vita-
min-E-rich margarines are generally also rich in polyun-
saturated fatty acids, and they also tend to be lower in
trans [42]. Thus, vitamin E content may be a marker for
the type of margarine, and the data from the Iowa
women [71] are compatible with a protective effect of
soft tub margarines.
5. Conclusion
Our findings support recent FAO/WHO recommen-
dations that consumers should replace hard fats with
liquid oils and soft fats to reduce the intake of both
saturated and trans fatty acids [72]. However, con-
sumers can make optimal choices only if trans contents
are reported on the labels of food fats.
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